27/09/2021 NEW HAVEN, Conn., 27 sept. 2021 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE : BHVN) a annoncé aujourd’hui les résultats d’une analyse ciblée d’un essai clinique sur le verdiperstat dans l’atrophie multisystématisée (AMS). Le...
09/27/2021 NEW HAVEN, Conn., 27 set 2021 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) oggi ha annunciato i risultati ottenuti da un’analisi mirata di una sperimentazione clinica di verdiperstat nell’atrofia multisistemica (MSA)....
27/09/2021 NEW HAVEN, Conn., 27 de septiembre de 2021 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) anunció hoy los resultados de un análisis centrado en un ensayo clínico de verdiperstat en la atrofia multisistémica (AMS). El verdiperstat...
VERY DISAPPOINTING NEWS FROM BIOHAVEN RE: VERDIPERSTAT (& M-STAR STUDY)Biohaven remains committed to neuroscience and to the MSA community. They intend to analyze the results further. Biohaven has met with Defeat MSA Alliance all along in this process and informed...
Proaktive Fragen: können online veröffentlicht werden 1) Kann ich trotzdem an der Studie teilnehmen? Die Aufnahme in die Phase-III-Studie wurde im Juli 2020 abgeschlossen. 2) Wann werden die Ergebnisse der Phase-III-Studie voraussichtlich bekannt sein? Biohaven...
Preguntas proactivas: se pueden publicar en línea ¿Puedo seguir uniéndome al ensayo? La inscripción para el estudio en fase III cerró en julio de 2020. ¿Cuándo se espera que...
Questions proactives : peuvent être publiées en ligne 1) Puis-je quand même participer à l’essai? L’inscription à l’étude de phase 3 a pris fin en juillet 2020. 2) Quand pourrions-nous connaître les résultats de l’étude de phase 3? Biohaven s’attend à ce que les...
Domande proattive: possono essere pubblicate online Posso ancora partecipare alla sperimentazione?L’arruolamento per lo studio di fase 3 è stato chiuso a luglio 2020.Quando ci si aspetta di conoscere i risultati dello studio di fase 3?L’aspettativa di Biohaven è che i...
Timeline: International Phase 3 Clinical Trial of Verdiperstat in Multiple System Atrophy "Top line results from the study are expected to be available in 3rd Quarter of 2021 and will help to characterize the potential benefits and risks of Verdiperstat in MSA. After...
Defeat MSA Alliance Board of Directors and affiliated charities in the MSA United Consortium are pleased to announce the second Annual All-Community MSA Conference to be held 24 September - 2 October, 2021. This year's conference will include several exciting...
A Few of Activities For MSA Awareness Month... 1) EAT CAKE. GIVE HOPE. DEFEAT MSA. Join Annual Cake 4 A Cure Campaign! Read About an Amazing and Successful Campaign: Cake4aCure.org Also, the Facebook page for more details: https://www.facebook.com/Cake4aCure 2)...
Defeat MSA Alliance and the MSA United International Consortium charities are excited to announce the world’s first MSA virtual conference! The Global MSA Virtual Support Symposium is Free for all and will take place on Saturday, the 19th of September, 2020. We...
27/09/2021 NEW HAVEN, Conn., 27 de setembro de 2021 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) anunciou hoje os resultados de uma análise focada de um ensaio clínico de verdiperstat na atrofia do sistema múltiplo (MSA). O verdiperstat...
MSA United International
29924 Jefferson Avenue
Saint Clair Shores, Michigan 48082
USA
0 Comments